Skip to content

Microplastic Analysis in Pediatric Inflammatory Bowel Disease

Analysis of Microplastics in Pediatric Inflammatory Bowel Disease Using Raman Spectroscopy: A Multi-Matrix Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07141238
Acronym
MAP-IBD
Enrollment
40
Registered
2025-08-26
Start date
2025-06-15
Completion date
2026-06-30
Last updated
2025-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn Disease, Inflammatory Bowel Disease (IBD), Pediatric Inflammatory Bowel Diseases, Ulcerative Colitis (UC)

Keywords

Microplastics, Pediatric Inflammatory Bowel Disease, Raman Spectroscopy, Environmental exposure, Ulcerative Colitis, Crohn's Disease

Brief summary

The goal of this observational study is to measure and compare the presence of microplastics in children with inflammatory bowel disease (IBD) and children without IBD. The main questions it aims to answer are: Are microplastics detectable in different biological samples from children? Are there differences in microplastic burden between children with and without IBD? Researchers will collect biological samples including: intestinal tissue (from routine endoscopy), stool, urine, blood. Raman spectroscopy will be used to detect and characterize microplastics in each sample type. Participants will not receive any medication or intervention as part of this study. All samples will be collected during standard clinical procedures.

Interventions

OTHEREnvironmental microplastic exposure

Exposure to environmental microplastics measured by their presence in intestinal tissue, blood, urine, and stool using Raman spectroscopy. This study does not assign any exposure or treatment; it investigates the existing presence of microplastics as an environmental factor of interest.

Sponsors

Medical University of Gdansk
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* Age \<18 years * Undergoing clinically indicated gastrointestinal endoscopy * For IBD group: confirmed diagnosis of Crohn's disease or ulcerative colitis * For control group: no current or past diagnosis of IBD

Exclusion criteria

* Age 18 years or older * Lack of informed consent from legal guardian * Lack of written assent from the participant if age ≥13 years

Design outcomes

Primary

MeasureTime frameDescription
Presence and concentration of microplastics in intestinal tissue samplesDay of endoscopy (Baseline)Quantification of microplastics (number of particles per gram of tissue) detected using Raman spectroscopy in intestinal mucosal biopsies collected during clinically indicated endoscopy.

Secondary

MeasureTime frameDescription
Comparison of microplastic burden between children with IBD and controlsBaseline (Day of sample collection)Assessment of differences in all biological matrices (tissue, stool, blood, urine) between children with inflammatory bowel disease and controls

Countries

Poland

Contacts

Primary ContactDominika Marszk, MD
dsierdzinska@gumed.edu.pl+48609619101

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026